Disparities in Opioid Use Disorder Treatment Admissions in the United States

**Objectives:** The Cincinnati region has been at the epicenter of the nation’s unfolding opioid epidemic. The objectives of this study were twofold: (1) to compare the Cincinnati region to the United States in length of time to obtain treatment and planned medication-assisted therapy for the treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter J. Mallow, Michael Mercado, Michael Topmiller
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2020-06-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2020.13266
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860302243954688
author Peter J. Mallow
Michael Mercado
Michael Topmiller
author_facet Peter J. Mallow
Michael Mercado
Michael Topmiller
author_sort Peter J. Mallow
collection DOAJ
description **Objectives:** The Cincinnati region has been at the epicenter of the nation’s unfolding opioid epidemic. The objectives of this study were twofold: (1) to compare the Cincinnati region to the United States in length of time to obtain treatment and planned medication-assisted therapy for the treatment for opioid use disorder (OUD); and (2) to assess racial disparities within the Cincinnati region in wait time and type of treatment. **Methods:** The 2017 Treatment Episode Data Set: Admissions (TEDS-A) from the Substance Abuse and Mental Health Services Administration (SAMHSA) was used to identify a cohort of eligible individuals with a primary substance use of opioids, including opioid derivatives. Logistic regression models were performed to assess the differences for treatment wait time and type of planned treatment. Model covariates included patient demographics and socioeconomic characteristics. Three different models were performed to assess the influence of covariates of the outcomes. **Results:** There were 678&#8239;766 US and 3298 Cincinnati region individuals admitted for OUD treatment in 2017. The rate per 1000 for treatment admissions was 2.08 and 1.51 (P value < 0.0001) for the United States and Cincinnati, respectively. The fully saturated regression results found that the odds of Cincinnati individuals receiving planned medication-assisted therapy were 0.497 (95% CI, 0.451–0.546; P value < 0.001). The odds of waiting longer for treatment in Cincinnati were higher than in the United States as a whole: 2.33 (95% CI, 2.19–2.48; P value < 0.001). In Cincinnati, there were 3102 Caucasian, 123 African American, and 73 Other admissions. The fully saturated model results found that Caucasians and Other had an increased likelihood of receiving planned medication-assisted therapy (OR 1.89, P value 0.039; OR 7.07, P value 0.002, respectively) compared to African Americans. Within Cincinnati, there was not a statistically significant difference in the likelihood of waiting time to receive treatment by race. **Conclusion:** Individuals seeking treatment for OUD in Cincinnati were less likely to receive planned medication-assisted therapy and were more likely to wait longer than individuals in the United States as a whole. These results suggest that the demand for treatment is greater than the supply in Cincinnati. Within Cincinnati, there does not appear to be a racial disparity in treatment type or length of time to receive treatment for OUD.
format Article
id doaj-art-aa87b08fedd84966b90c0becd2e2e949
institution Kabale University
issn 2327-2236
language English
publishDate 2020-06-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj-art-aa87b08fedd84966b90c0becd2e2e9492025-02-10T16:13:08ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362020-06-0171Disparities in Opioid Use Disorder Treatment Admissions in the United StatesPeter J. MallowMichael MercadoMichael Topmiller**Objectives:** The Cincinnati region has been at the epicenter of the nation’s unfolding opioid epidemic. The objectives of this study were twofold: (1) to compare the Cincinnati region to the United States in length of time to obtain treatment and planned medication-assisted therapy for the treatment for opioid use disorder (OUD); and (2) to assess racial disparities within the Cincinnati region in wait time and type of treatment. **Methods:** The 2017 Treatment Episode Data Set: Admissions (TEDS-A) from the Substance Abuse and Mental Health Services Administration (SAMHSA) was used to identify a cohort of eligible individuals with a primary substance use of opioids, including opioid derivatives. Logistic regression models were performed to assess the differences for treatment wait time and type of planned treatment. Model covariates included patient demographics and socioeconomic characteristics. Three different models were performed to assess the influence of covariates of the outcomes. **Results:** There were 678&#8239;766 US and 3298 Cincinnati region individuals admitted for OUD treatment in 2017. The rate per 1000 for treatment admissions was 2.08 and 1.51 (P value < 0.0001) for the United States and Cincinnati, respectively. The fully saturated regression results found that the odds of Cincinnati individuals receiving planned medication-assisted therapy were 0.497 (95% CI, 0.451–0.546; P value < 0.001). The odds of waiting longer for treatment in Cincinnati were higher than in the United States as a whole: 2.33 (95% CI, 2.19–2.48; P value < 0.001). In Cincinnati, there were 3102 Caucasian, 123 African American, and 73 Other admissions. The fully saturated model results found that Caucasians and Other had an increased likelihood of receiving planned medication-assisted therapy (OR 1.89, P value 0.039; OR 7.07, P value 0.002, respectively) compared to African Americans. Within Cincinnati, there was not a statistically significant difference in the likelihood of waiting time to receive treatment by race. **Conclusion:** Individuals seeking treatment for OUD in Cincinnati were less likely to receive planned medication-assisted therapy and were more likely to wait longer than individuals in the United States as a whole. These results suggest that the demand for treatment is greater than the supply in Cincinnati. Within Cincinnati, there does not appear to be a racial disparity in treatment type or length of time to receive treatment for OUD.https://doi.org/10.36469/jheor.2020.13266
spellingShingle Peter J. Mallow
Michael Mercado
Michael Topmiller
Disparities in Opioid Use Disorder Treatment Admissions in the United States
Journal of Health Economics and Outcomes Research
title Disparities in Opioid Use Disorder Treatment Admissions in the United States
title_full Disparities in Opioid Use Disorder Treatment Admissions in the United States
title_fullStr Disparities in Opioid Use Disorder Treatment Admissions in the United States
title_full_unstemmed Disparities in Opioid Use Disorder Treatment Admissions in the United States
title_short Disparities in Opioid Use Disorder Treatment Admissions in the United States
title_sort disparities in opioid use disorder treatment admissions in the united states
url https://doi.org/10.36469/jheor.2020.13266
work_keys_str_mv AT peterjmallow disparitiesinopioidusedisordertreatmentadmissionsintheunitedstates
AT michaelmercado disparitiesinopioidusedisordertreatmentadmissionsintheunitedstates
AT michaeltopmiller disparitiesinopioidusedisordertreatmentadmissionsintheunitedstates